The Rheumatologist
You are here: Home / Articles / B Cell-Directed Therapy May Delay RA Development in High-Risk Patients

B Cell-Directed Therapy May Delay RA Development in High-Risk Patients

• By

Leave a Reply

Your email address will not be published. Required fields are marked *

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR/ARP Meeting Abstracts

Browse and search abstracts from the ACR/ARP Annual Meetings going back to 2012.

Visit the ACR/ARP Meeting Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »